A detailed history of Cullinan Associates Inc transactions in Stryker Corp stock. As of the latest transaction made, Cullinan Associates Inc holds 7,365 shares of SYK stock, worth $2.69 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
7,365
Previous 7,731 4.73%
Holding current value
$2.69 Million
Previous $2.63 Million 1.14%
% of portfolio
0.15%
Previous 0.15%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$315.94 - $371.96 $115,634 - $136,137
-366 Reduced 4.73%
7,365 $2.66 Million
Q2 2024

Jul 10, 2024

BUY
$324.3 - $354.67 $227,010 - $248,269
700 Added 9.96%
7,731 $2.63 Million
Q1 2024

Apr 18, 2024

SELL
$293.94 - $358.71 $3.74 Million - $4.56 Million
-12,715 Reduced 64.39%
7,031 $2.52 Million
Q4 2023

Jan 24, 2024

SELL
$253.85 - $299.46 $348,282 - $410,859
-1,372 Reduced 6.5%
19,746 $5.91 Million
Q3 2023

Oct 11, 2023

BUY
$266.54 - $302.43 $226,559 - $257,065
850 Added 4.19%
21,118 $5.77 Million
Q2 2023

Jul 14, 2023

SELL
$271.49 - $305.09 $224,250 - $252,004
-826 Reduced 3.92%
20,268 $6.18 Million
Q1 2023

Apr 05, 2023

SELL
$246.13 - $285.47 $14,029 - $16,271
-57 Reduced 0.27%
21,094 $6.02 Million
Q4 2022

Jan 11, 2023

SELL
$205.51 - $253.93 $61,653 - $76,179
-300 Reduced 1.4%
21,151 $5.17 Million
Q3 2022

Oct 19, 2022

SELL
$189.27 - $231.83 $162,772 - $199,373
-860 Reduced 3.85%
21,451 $4.35 Million
Q2 2022

Jul 08, 2022

SELL
$194.09 - $276.37 $1.4 Million - $1.99 Million
-7,200 Reduced 24.4%
22,311 $4.44 Million
Q1 2022

Apr 21, 2022

SELL
$245.33 - $277.77 $94,697 - $107,219
-386 Reduced 1.29%
29,511 $7.89 Million
Q4 2021

Jan 07, 2022

SELL
$236.63 - $276.44 $47,326 - $55,288
-200 Reduced 0.66%
29,897 $8 Million
Q3 2021

Oct 08, 2021

BUY
$248.9 - $280.09 $88,359 - $99,431
355 Added 1.19%
30,097 $7.94 Million
Q2 2021

Jul 07, 2021

SELL
$242.95 - $267.0 $12,147 - $13,350
-50 Reduced 0.17%
29,742 $7.73 Million
Q1 2021

Apr 20, 2021

SELL
$221.01 - $248.82 $50,832 - $57,228
-230 Reduced 0.77%
29,792 $7.26 Million
Q4 2020

Jan 14, 2021

BUY
$202.01 - $245.04 $22,221 - $26,954
110 Added 0.37%
30,022 $7.36 Million
Q3 2020

Oct 09, 2020

SELL
$177.77 - $215.81 $1.42 Million - $1.73 Million
-7,995 Reduced 21.09%
29,912 $6.23 Million
Q2 2020

Jul 07, 2020

BUY
$144.67 - $207.03 $157,690 - $225,662
1,090 Added 2.96%
37,907 $6.83 Million
Q1 2020

Apr 01, 2020

BUY
$126.5 - $225.1 $277,667 - $494,094
2,195 Added 6.34%
36,817 $6.13 Million
Q4 2019

Jan 15, 2020

BUY
$197.98 - $220.53 $1.35 Million - $1.5 Million
6,802 Added 24.45%
34,622 $7.27 Million
Q3 2019

Oct 01, 2019

SELL
$205.4 - $221.82 $415,935 - $449,185
-2,025 Reduced 6.79%
27,820 $6.02 Million
Q2 2019

Jul 16, 2019

SELL
$180.24 - $205.58 $1.35 Million - $1.54 Million
-7,470 Reduced 20.02%
29,845 $6.14 Million
Q1 2019

Apr 30, 2019

BUY
$152.46 - $198.0 $1.3 Million - $1.69 Million
8,547 Added 29.71%
37,315 $7.37 Million
Q4 2018

Jan 11, 2019

BUY
$145.0 - $178.65 $457,330 - $563,462
3,154 Added 12.31%
28,768 $4.51 Million
Q3 2018

Oct 19, 2018

BUY
$163.25 - $177.68 $1.17 Million - $1.28 Million
7,190 Added 39.03%
25,614 $4.55 Million
Q2 2018

Jul 09, 2018

BUY
$155.17 - $179.78 $2.86 Million - $3.31 Million
18,424 New
18,424 $3.11 Million

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $138B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Cullinan Associates Inc Portfolio

Follow Cullinan Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullinan Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cullinan Associates Inc with notifications on news.